Ahn S, Jung S
Adv Exp Med Biol. 2021; 1187:363-379.
PMID: 33983588
DOI: 10.1007/978-981-32-9620-6_18.
Charpentier M, Gutierrez C, Guillaudeux T, Verhoest G, Pedeux R
Cancers (Basel). 2021; 13(7).
PMID: 33916038
PMC: 8036846.
DOI: 10.3390/cancers13071650.
Anitha D, Venkatesh T
Indian J Clin Biochem. 2012; 15(2):114-8.
PMID: 23105251
PMC: 3453963.
DOI: 10.1007/BF02883738.
Kakuno Y, Yamada T, Mori H, Narabayashi I
Hum Cell. 2008; 21(2):46-55.
PMID: 18397474
DOI: 10.1111/j.1749-0774.2008.00050.x.
Gold P, Freedman S
J Exp Med. 1965; 121:439-62.
PMID: 14270243
PMC: 2137957.
DOI: 10.1084/jem.121.3.439.
Some aspects of the problem of immunity against transplanted and spontaneous tumors.
Hirsch H
Bacteriol Rev. 1962; 26:336-53.
PMID: 13961186
PMC: 441155.
DOI: 10.1128/br.26.3.336-353.1962.
The correlation of CA15.3 and TPS with tumor course in patients with metastatic breast cancer.
Pronk L, Stoter G, van Putten W, de Wit R
J Cancer Res Clin Oncol. 1997; 123(2):128-32.
PMID: 9030253
DOI: 10.1007/BF01269892.
Tissue polypeptide specific antigen for the detection of lymphoproliferative diseases induced by cyclosporin.
Vogl M, Griesmacher A, Grimm M, Klepetko W, Muller M
J Clin Pathol. 1995; 48(11):1039-44.
PMID: 8543628
PMC: 503011.
DOI: 10.1136/jcp.48.11.1039.
A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate....
Pasanen P, Eskelinen M, Partanen K, Pikkarainen P, Penttila I, Alhava E
Br J Cancer. 1994; 69(3):562-5.
PMID: 8123488
PMC: 1968866.
DOI: 10.1038/bjc.1994.102.
Detection of an inhibitor of cell division in cultures of tumour cells with immunosuppressive activity in vitro.
Werkmeister J, Zbroja R, McCarthy W, Hersey P
Clin Exp Immunol. 1980; 40(1):168-77.
PMID: 7389213
PMC: 1536937.
Determination of TPA levels in breast cancer and controls.
Mross K, Mross B, Wolfrum D, Rauschecker H
Klin Wochenschr. 1983; 61(9):461-8.
PMID: 6865275
DOI: 10.1007/BF02664334.
Serum tissue polypeptide antigen (TPA) in thyroid cancer.
Martino E, BAMBINI G, Aghini-Lombardi F, Motz E, Pacini F, Lari R
J Endocrinol Invest. 1984; 7(3):249-52.
PMID: 6547969
DOI: 10.1007/BF03348433.
Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker.
Weber K, Osborn M, Moll R, Wiklund B, LUNING B
EMBO J. 1984; 3(11):2707-14.
PMID: 6210199
PMC: 557754.
DOI: 10.1002/j.1460-2075.1984.tb02198.x.
A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue.
Dickinson J, CASPARY E, Field E
Br J Cancer. 1973; 27(2):99-105.
PMID: 4735112
PMC: 2008838.
DOI: 10.1038/bjc.1973.13.
Epidemiology and endocrinology of benign breast disease.
Wang D, Fentiman I
Breast Cancer Res Treat. 1985; 6(1):5-36.
PMID: 3902125
DOI: 10.1007/BF01806008.
Serum levels of six tumor markers in patients with benign and malignant gynecological disease.
Fukazawa I, Inaba N, Ota Y, Sato N, Shirotake S, Iwasawa H
Arch Gynecol Obstet. 1988; 243(2):61-8.
PMID: 3401042
DOI: 10.1007/BF00932971.
Immunoradiometrical measurement of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) in pregnancy and at delivery.
Itahashi K, Inaba N, Fukazawa I, Takamizawa H
Arch Gynecol Obstet. 1988; 243(4):191-7.
PMID: 3223775
DOI: 10.1007/BF00932267.
Relation between serum levels of tissue polypeptide antigen (TPA) and cancer antigen 125 (CA125) and their immunohistochemical identification in benign and malignant gynecological disease.
Fukazawa I, Inaba N, Ota Y, Sato N, Shirotake S, Iwasawa H
Arch Gynecol Obstet. 1988; 243(1):41-50.
PMID: 3165614
DOI: 10.1007/BF00931550.
Experiments with tissue cultures from a human ovarian serous cystadenocarcinoma producing cancer antigen 125 (CA125), tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA).
Fukazawa I, Inaba N, Ota Y, Sato N, Shirotake S, Iwasawa H
Arch Gynecol Obstet. 1988; 243(2):69-81.
PMID: 3165255
DOI: 10.1007/BF00932972.
Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma.
Carbin B, Ekman P, Eneroth P, Nilsson B
Urol Res. 1989; 17(5):269-72.
PMID: 2815427
DOI: 10.1007/BF00262980.
